The Terpene D-Limonene Reduced THC-Induced Anxiety in Humans
In a double-blind crossover trial, vaporized d-limonene selectively reduced THC-induced anxiety and paranoia without affecting other THC effects, providing the first rigorous human evidence for a specific cannabis entourage effect.
Quick Facts
What This Study Found
Co-administration of 30mg THC with 15mg d-limonene significantly reduced ratings of "anxious/nervous" and "paranoid" compared to 30mg THC alone. Anxiety-like effects qualitatively decreased as d-limonene dose increased. D-limonene alone produced no effects different from placebo, and it did not alter THC pharmacokinetics or other THC effects.
Key Numbers
20 participants (12 in extended arm). THC doses: 15mg and 30mg. D-limonene doses: 1mg, 5mg, and 15mg. 30mg THC + 15mg d-limonene significantly reduced anxiety and paranoia ratings vs 30mg THC alone. D-limonene did not alter THC plasma concentrations.
How They Did This
Double-blind, placebo-controlled crossover trial. 20 healthy intermittent cannabis users completed 9 outpatient sessions (subset of 12 completed a 10th). They inhaled vaporized THC (15mg or 30mg), d-limonene (1mg or 5mg), combinations, or placebo. Outcomes included subjective effects, cognition, psychomotor performance, vital signs, and plasma levels.
Why This Research Matters
This is one of the first rigorous human studies to demonstrate a specific entourage effect in cannabis. The selectivity is key: d-limonene reduced only the anxiety component of THC without blunting its other effects, suggesting it could increase THC's therapeutic index.
The Bigger Picture
The entourage effect has been widely discussed but rarely tested rigorously in humans. This study provides mechanistic evidence that specific terpene-cannabinoid combinations can modify the cannabis experience in predictable, therapeutically useful ways.
What This Study Doesn't Tell Us
Relatively small sample (20 participants). Only healthy intermittent cannabis users were studied; effects may differ in daily users or patients. The inhalation route may not translate to oral products. Only one terpene was tested.
Questions This Raises
- ?Would d-limonene reduce anxiety in clinical populations using THC for medical purposes?
- ?Does the anxiolytic effect extend to oral cannabis formulations?
- ?What is the mechanism by which d-limonene selectively modulates anxiety?
Trust & Context
- Key Stat:
- D-limonene selectively reduced THC anxiety without altering other effects
- Evidence Grade:
- Well-designed double-blind crossover RCT with dose-response data, though small sample size limits generalizability.
- Study Age:
- 2024 study
- Original Title:
- Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis.
- Published In:
- Drug and alcohol dependence, 257, 111267 (2024)
- Authors:
- Spindle, Tory R(18), Zamarripa, C Austin(9), Russo, Ethan(3), Pollak, Lauren, Bigelow, George, Ward, Alexandra M, Tompson, Bridget, Sempio, Cristina, Shokati, Touraj, Klawitter, Jost, Christians, Uwe, Vandrey, Ryan
- Database ID:
- RTHC-05731
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Can anything reduce the anxiety caused by THC?
This study found that the terpene d-limonene, found naturally in citrus fruits and some cannabis strains, selectively reduced THC-induced anxiety and paranoia when co-administered via vaporization.
Is this proof of the cannabis entourage effect?
It is some of the strongest human evidence yet for a specific entourage interaction. D-limonene selectively modulated one aspect of THC (anxiety) without changing others, suggesting a targeted synergistic mechanism.
Read More on RethinkTHC
- anxiety-leaving-house-weed-withdrawal-agoraphobia
- anxiety-response-technique-weed-withdrawal
- anxiety-toolkit-weed-withdrawal
- anxiety-worse-after-quitting-weed
- breathing-exercises-weed-withdrawal-anxiety
- cannabis-induced-anxiety
- does-weed-help-anxiety
- grounding-techniques-weed-withdrawal
- health-anxiety-weed-withdrawal
- manage-anxiety-without-weed
- quitting-weed-anxiety-disorder
- quitting-weed-anxiety-medication-ssri
- self-medicating-anxiety-with-weed
- therapy-quitting-weed-anxiety
- weed-and-anxiety
- weed-biphasic-effect-anxiety
- weed-generalized-anxiety-disorder
- weed-panic-attacks
- weed-paranoia
- weed-social-anxiety
- weed-tolerance-anxiety-stopped-working
- weed-withdrawal-anxiety
- weed-withdrawal-panic-attacks-night
- weed-withdrawal-work-anxiety
- withdrawal-anxiety-vs-real-anxiety
Cite This Study
https://rethinkthc.com/research/RTHC-05731APA
Spindle, Tory R; Zamarripa, C Austin; Russo, Ethan; Pollak, Lauren; Bigelow, George; Ward, Alexandra M; Tompson, Bridget; Sempio, Cristina; Shokati, Touraj; Klawitter, Jost; Christians, Uwe; Vandrey, Ryan. (2024). Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis.. Drug and alcohol dependence, 257, 111267. https://doi.org/10.1016/j.drugalcdep.2024.111267
MLA
Spindle, Tory R, et al. "Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis.." Drug and alcohol dependence, 2024. https://doi.org/10.1016/j.drugalcdep.2024.111267
RethinkTHC
RethinkTHC Research Database. "Vaporized D-limonene selectively mitigates the acute anxioge..." RTHC-05731. Retrieved from https://rethinkthc.com/research/spindle-2024-vaporized-dlimonene-selectively-mitigates
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.